Category: Acquired Immune Deficiency Syndrome

Behind the Scenes, McKinsey Guided Companies at the Center of the Opioid Crisis

Acquired Immune Deficiency Syndrome, Appalachian Region, Centers for Disease Control and Prevention, Consultants, Drug Abuse and Traffic, Drug Enforcement Administration, Drugs (Pharmaceuticals), Endo, Food and Drug Administration, Johnson & Johnson, McKinsey & Co, Opana, Opioids and Opiates, OxyContin (Drug), Pain-Relieving Drugs, Poppies, Purdue Pharma, United States / June 29, 2022 June 29, 2022

The consulting firm offered clients “in-depth experience in narcotics,” from poppy fields to pills more powerful than Purdue’s OxyContin.

Seeking Covid Pills, Poor Nations Fear Repeat of AIDS Crisis

Acquired Immune Deficiency Syndrome, Biden, Joseph R Jr, Coronavirus (2019-nCoV), Drugs (Pharmaceuticals), Generic Brands and Products, Income Inequality, Merck & Company Inc, Molnupiravir (Drug), Paxlovid (Drug), Pfizer Inc, Tests (Medical), Third World and Developing Countries, United Nations Children's Fund, United States International Relations, World Health Organization / May 11, 2022 May 11, 2022

The antiviral pills, plentiful in the United States, are scarce overseas. Health groups and the White House want to expand access but face obstacles that evoke the H.I.V. epidemic.

Seeking Covid Pills, Poor Nations Fear Repeat of AIDS Crisis

The antiviral pills, plentiful in the United States, are scarce overseas. Health groups and the White House want to expand access but face obstacles that evoke the H.I.V. epidemic.

Seeking Covid Pills, Poor Nations Fear Repeat of AIDS Crisis

The antiviral pills, plentiful in the United States, are scarce overseas. Health groups and the White House want to expand access but face obstacles that evoke the H.I.V. epidemic.

Seeking Covid Pills, Poor Nations Fear Repeat of AIDS Crisis

Acquired Immune Deficiency Syndrome, Coronavirus (2019-nCoV), Drugs (Pharmaceuticals), Income Inequality, Molnupiravir (Drug), Paxlovid (Drug), Tests (Medical), United States International Relations, World Health Organization / May 8, 2022 May 8, 2022

The antiviral pills, plentiful in the United States, are scarce overseas. Health groups and the White House want to expand access but face obstacles that evoke the H.I.V. epidemic.

Este no es el fin de la pandemia del coronavirus. Veamos lo que pasó con el sida

Acquired Immune Deficiency Syndrome, Coronavirus (2019-nCoV), Drugs (Pharmaceuticals), Vaccination and Immunization / February 18, 2022 February 18, 2022

Todos queremos volver a la normalidad y declarar el fin del peligro de la COVID-19. Pero eso no es cierto para una buena parte del mundo.

Este no es el fin de la pandemia del coronavirus. Veamos lo que pasó con el sida

Acquired Immune Deficiency Syndrome, Coronavirus (2019-nCoV), Drugs (Pharmaceuticals), Vaccination and Immunization / February 18, 2022 February 18, 2022

Todos queremos volver a la normalidad y declarar el fin del peligro de la COVID-19. Pero eso no es cierto para una buena parte del mundo.

The Moral Danger of Declaring the Pandemic Over Too Soon

Acquired Immune Deficiency Syndrome, Coronavirus (2019-nCoV), Drugs (Pharmaceuticals), Vaccination and Immunization / February 17, 2022 February 17, 2022

There has to be a better way out of the rubble of the past two years.

The Moral Danger of Declaring the Pandemic Over Too Soon

Acquired Immune Deficiency Syndrome, Coronavirus (2019-nCoV), Drugs (Pharmaceuticals), Vaccination and Immunization / February 17, 2022 February 17, 2022

There has to be a better way out of the rubble of the past two years.

In South Africa, Success Against H.I.V. Offers Hope

Acquired Immune Deficiency Syndrome, Africa, Drugs (Pharmaceuticals), South Africa, Two Thousands (Decade), Zambia / January 12, 2022 January 12, 2022

A former Africa correspondent, who covered the height of the AIDS epidemic there 15 years ago, finds lessons in the remarkable progress against that virus for our current fight.

In South Africa, Success Against H.I.V. Offers Hope

Acquired Immune Deficiency Syndrome, Africa, Drugs (Pharmaceuticals), South Africa, Two Thousands (Decade), Zambia / January 12, 2022 January 12, 2022

A former Africa correspondent, who covered the height of the AIDS epidemic there 15 years ago, finds lessons in the remarkable progress against that virus for our current fight.

In Southern Africa, Success Against H.I.V. Offers Hope for Beating Back Another Virus

Acquired Immune Deficiency Syndrome, Africa, Drugs (Pharmaceuticals), South Africa, Two Thousands (Decade), Zambia / January 11, 2022 January 11, 2022

A former Africa correspondent, who covered the height of the AIDS epidemic there 15 years ago, finds lessons in the remarkable progress against that virus for our current fight.

In Southern Africa, Success Against H.I.V. Offers Hope for Beating Back Another Virus

Acquired Immune Deficiency Syndrome, Africa, Drugs (Pharmaceuticals), South Africa, Two Thousands (Decade), Zambia / January 11, 2022 January 11, 2022

A former Africa correspondent, who covered the height of the AIDS epidemic there 15 years ago, finds lessons in the remarkable progress against that virus for our current fight.

The Variant Hunters: Inside South Africa’s Effort to Stanch Dangerous Mutations

Acquired Immune Deficiency Syndrome, audio-neutral-informative, Coronavirus (2019-nCoV), Coronavirus Omicron Variant, Disease Rates, Drugs (Pharmaceuticals), Immune System, Laboratories and Scientific Equipment, Research, South Africa, Vaccination and Immunization / December 6, 2021 December 6, 2021

Scientists in a cutting-edge laboratory do part of the work. Local health workers on foot do the rest.

What Can One Life Tell Us About the Battle Against H.I.V.?

Acquired Immune Deficiency Syndrome, Drugs (Pharmaceuticals), Global Fund to Fight AIDS, Tuberculosis and Malaria, internal-open-access, President's Emergency Plan for AIDS Relief, UNAIDS / December 2, 2021 December 2, 2021

In 2001, U.N. estimates suggested 150 million people would be infected with H.I.V. by 2021. That preceded an ambitious global campaign to curb the virus. How well did it work?

What Can One Life Tell Us About the Battle Against H.I.V.?

In 2001, U.N. estimates suggested 150 million people would be infected with H.I.V. by 2021. That preceded an ambitious global campaign to curb the virus. How well did it work?

What Can One Life Tell Us About the Battle Against H.I.V.?

In 2001, U.N. estimates suggested 150 million people would be infected with H.I.V. by 2021. That preceded an ambitious global campaign to curb the virus. How well did it work?

An Experimental H.I.V. Vaccine Fails in Africa

Acquired Immune Deficiency Syndrome, Africa, Clinical Trials, Drugs (Pharmaceuticals), Johnson & Johnson, South Africa, Vaccination and Immunization, your-feed-science / September 6, 2021 September 6, 2021

Researchers ended a large trial in South Africa after finding that an experimental vaccine offered little protection.

An Experimental H.I.V. Vaccine Fails in Africa

Researchers ended a large trial in South Africa after finding that an experimental vaccine offered little protection.

A U.N. Declaration on Ending AIDS Should Have Been Easy. It Wasn’t.

Acquired Immune Deficiency Syndrome, Belarus, China, Coronavirus (2019-nCoV), Discrimination, Drugs (Pharmaceuticals), European Union, Homosexuality and Bisexuality, Intellectual Property, Inventions and Patents, Iran, Prostitution, Russia, Sex Education, Switzerland, United Nations, United States, Vaccination and Immunization, your-feed-science / June 8, 2021 June 8, 2021

Even with U.N.’s previous goals unmet, delegates tried to water down provisions regarding protections for vulnerable populations and patents for essential drugs.

An U.N. Declaration on Ending AIDS Should Have Been Easy. It Wasn’t.

Even with U.N.’s previous goals unmet, delegates tried to water down provisions regarding protections for vulnerable populations and patents for essential drugs.

John C. Martin, 69, Dies; Led Drugmaker in Breakthroughs

Acquired Immune Deficiency Syndrome, Deaths (Obituaries), Drugs (Pharmaceuticals), Gilead Sciences Inc, hepatitis, Martin, John C (1951-2021), Sovaldi (Drug), Tamiflu (Drug), Truvada (Drug) / April 28, 2021 April 28, 2021

A chemist by training, he turned Gilead Sciences into a leading, and lucrative, innovator with single-pill treatments for H.I.V. and hepatitis C.

John C. Martin, 69, Dies; Led Drugmaker in Breakthroughs

Acquired Immune Deficiency Syndrome, Deaths (Obituaries), Drugs (Pharmaceuticals), Gilead Sciences Inc, H.I.V., hepatitis, Martin, John C (1951-2021), Sovaldi (Drug), Tamiflu (Drug), Truvada (Drug) / April 27, 2021 April 27, 2021

A chemist by training, he turned Gilead Sciences into a leading, and lucrative, innovator with single-pill treatments for H.I.V. and hepatitis C.

F.D.A. Approves Monthly Shots to Treat H.I.V.

Acquired Immune Deficiency Syndrome, Drugs (Pharmaceuticals), Food and Drug Administration, United States, your-feed-science / January 22, 2021 January 22, 2021

A combination of two injectable drugs will provide an alternative to daily pills for people with H.I.V.

F.D.A. Approves Monthly Shots to Treat H.I.V.

Acquired Immune Deficiency Syndrome, Drugs (Pharmaceuticals), Food and Drug Administration, United States, your-feed-science / January 22, 2021 January 22, 2021

A combination of two injectable drugs will provide an alternative to daily pills for people with H.I.V.

F.D.A. Approves Monthly Shots to Treat H.I.V.

Acquired Immune Deficiency Syndrome, Drugs (Pharmaceuticals), Food and Drug Administration, United States, your-feed-science / January 22, 2021 January 22, 2021

A combination of two injectable drugs will provide an alternative to daily pills for people with H.I.V.

F.D.A. Approves Monthly Shots to Treat H.I.V.

Acquired Immune Deficiency Syndrome, Drugs (Pharmaceuticals), Food and Drug Administration, United States, your-feed-science / January 22, 2021 January 22, 2021

A combination of two injectable drugs will provide an alternative to daily pills for people with H.I.V.

F.D.A. Approves Monthly Shots to Treat H.I.V.

Acquired Immune Deficiency Syndrome, Drugs (Pharmaceuticals), Food and Drug Administration, United States, your-feed-science / January 22, 2021 January 22, 2021

A combination of two injectable drugs will provide an alternative to daily pills for people with H.I.V.

F.D.A. Approves Monthly Shots to Treat H.I.V.

Acquired Immune Deficiency Syndrome, Drugs (Pharmaceuticals), Food and Drug Administration, United States, your-feed-science / January 22, 2021 January 22, 2021

A combination of two injectable drugs will provide an alternative to daily pills for people with H.I.V.